Dilong Chen
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in ⓘ
-
- Ginseng Biological Effects and Applications 14
- Histone Deacetylase Inhibitors Research 3
-
- Cancer-related molecular mechanisms research 7
- Co-authors
- Jianhua Ran (17 shared papers)Rong Jiang (7 shared papers)Wei Xiong (7 shared papers)Xiaopeng Li (6 shared papers)Guowei Zuo (8 shared papers)Jing Xia (8 shared papers)Danyang Li (8 shared papers)Yi Chen (4 shared papers)
- Journals
- Oncology Reports (3 papers)Anti-Cancer Drugs (2 papers)Pharmaceuticals (2 papers)Oncotarget (2 papers)Molecular Catalysis (2 papers)
- Partner nations
- ChinaThailandUnited States
In The Last Decade
Dilong Chen
51 papers receiving 813 citations
Peers
Comparison fields: 5 of 103
- Pharmacology 89
- Cancer Research 148
- Molecular Biology 497
- Complementary and alternative medicine 44
- Organic Chemistry 131
Countries citing papers authored by Dilong Chen
This map shows the geographic impact of Dilong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilong Chen more than expected).
Fields of papers citing papers by Dilong Chen
This network shows the impact of papers produced by Dilong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilong Chen. The network helps show where Dilong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dilong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 60 | |
| 2 | 2018 | 46 | |
| 3 | 2018 | 46 | |
| 4 | 2020 | 43 | |
| 5 | 2015 | 43 | |
| 6 | 2014 | 41 | |
| 7 | 2015 | 40 | |
| 8 | 2019 | 38 | |
| 9 | 2014 | 37 | |
| 10 | 2016 | 34 | |
| 11 | 2014 | 27 | |
| 12 | 2023 | 26 | |
| 13 | 2016 | 26 | |
| 14 | 2014 | 23 | |
| 15 | 2021 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2019 | 21 | |
| 18 | 2020 | 19 | |
| 19 | 2017 | 17 | |
| 20 | 2009 | 17 |
About Dilong Chen
Dilong Chen is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Oncology and Physiology, having authored 54 papers that have together received 832 indexed citations. Recurring topics across this work include Ginseng Biological Effects and Applications (14 papers), Quinazolinone synthesis and applications (7 papers), Cancer-related molecular mechanisms research (7 papers), Synthesis and Biological Evaluation (4 papers), Nanomaterials for catalytic reactions (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Ferroptosis and cancer prognosis (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Pharmacology (89 citations), Cancer Research (148 citations), Molecular Biology (497 citations), Complementary and alternative medicine (44 citations) and Organic Chemistry (131 citations). Dilong Chen has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Jianhua Ran, Rong Jiang, Wei Xiong, Xiaopeng Li, Guowei Zuo, Jing Xia, Danyang Li, Yi Chen, Jing Li and Jing Li. Their work appears in journals such as Oncology Reports, Anti-Cancer Drugs, Pharmaceuticals, Oncotarget and Molecular Catalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.